Tech Center 1600 • Art Units: 1634 1682
This examiner grants 48% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18636097 | SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS | Non-Final OA | The Regents of the University of California |
| 17915071 | COVALENT CHEMISTRY ENABLES EXTRACELLULAR VESICLE PURIFICATION ON NANOSUBSTRATES ? TOWARD EARLY DETECTION OF HEPATOCELLULAR CARCINOMA | Non-Final OA | The Regents of the University of California |
| 17297356 | CHARACTERIZING METHYLATED DNA, RNA, AND PROTEINS IN THE DETECTION OF LUNG NEOPLASIA | Non-Final OA | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 17637410 | BLOOD GENE BIOMARKERS TO DIAGNOSE AND PREDICT ACUTE REJECTION IN LIVER TRANSPLANT RECIPIENTS | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17810820 | Treatment of Varicose Veins With Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Agonists | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 17554782 | tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease | Non-Final OA | Board of Regents, The University of Texas System |
| 17816152 | Tumor-on-a-chip | Non-Final OA | NEW YORK UNIVERSITY |
| 18742149 | METHODS FOR DETECTING AND TREATING PROPRANOLOL SENSITIVE TUMORS | Final Rejection | University of South Florida |
| 18095386 | NON-INVASIVE PRENATAL SAMPLE PREPARATION AND RELATED METHODS AND USES | Non-Final OA | Myriad Women's Health, Inc. |
| 18825852 | METHODS OF SELECTING AND TREATING CANCER SUBJECTS THAT ARE CANDIDATES FOR TREATMENT USING INHIBITORS OF PARP | Non-Final OA | Arima Genomics, Inc. |
| 18812671 | MICRONEEDLE DEVICES, AND USES THEREOF | Final Rejection | MiNDERA Corporation |
| 17599681 | ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS | Final Rejection | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS |
| 18751003 | METHOD FOR DETERMINING A CIRCADIAN RHYTHM OF A HUMAN SUBJECT | Non-Final OA | Charité - Universitätsmedizin Berlin |
| 17925054 | COMPOSITIONS AND METHODS OF DETECTION OF PRE-SYMPTOMATIC ALS | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17640823 | ASSOCIATION BETWEEN 4 COPIES OF EXON 3 OF fAIM AND PROGRESSIVE CHRONIC KIDNEY DISEASE IN CATS | Final Rejection | Washington State University |
| 17825580 | PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | Non-Final OA | Cedars-Sinai Medical Center |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | Non-Final OA | BAHCESEHIR UNIVERSITESI |
| 17654758 | ASSAY FOR THE DIAGNOSIS OF DERMATOPHYTOSIS | Final Rejection | EUROIMMUN Medizinische Labordiagnostika AG |
| 17905132 | OVARIAN RESERVE BIOMARKER AND USE THEREOF | Final Rejection | CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18021748 | BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF | Non-Final OA | BicycleTx Limited |
| 18250496 | METHOD, SYSTEM, AND KIT FOR IN SITU DETECTION OF MICRO RIBONUCLEIC ACID (miRNA) CARRIED BY EXTRACELLULAR VESICLES (EVs) | Non-Final OA | Qilu University of Technology (Shandong Academy of Sciences) |
| 18248133 | COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE | Non-Final OA | SCL HEALTHCARE, CO., LTD. |
| 18295893 | Synchronized Cell-Based Compositions | Non-Final OA | NeuroGX LLC |
| 18162133 | METHODS FOR THE RAPID ASSESSMENT OF THE EFFICACY OF CANCER THERAPY AND RELATED APPLICATIONS | Non-Final OA | aiGENE, Inc. |
| 18001601 | DETECTION OF METHYLATION STATUS | Non-Final OA | PentaBase Aps |
| 18062181 | DIAGNOSTIC SYSTEMS AND METHODS FOR THE ENRICHMENT OF MICROBIAL NUCLEIC ACIDS AND THE IDENTIFICATION OF MICROORGANISMS AND/OR RESISTANCE GENES BY IMMOBILIZED ADSORPTION | Non-Final OA | CENTERS FOR DISEASE CONTROL, MINISTRY OF HEALTH AND WELFARE |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | Non-Final OA | THE WASHINGTON UNIVERSITY |
| 17610724 | CAPTURE AND ANALYSIS OF TARGET GENOMIC REGIONS | Final Rejection | LGC GENOMICS LLC |
| 17268268 | DNA METHYLATION-RELATED MARKER FOR DIAGNOSING TUMOR, AND APPLICATION THEREOF | Final Rejection | SHANGHAI PUBLIC HEALTH CLINICAL CENTER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy